about
Modulation of amyloid-β aggregation by histidine-coordinating Cobalt(III) Schiff base complexes.Light-activated protein inhibition through photoinduced electron transfer of a ruthenium(II)-cobalt(III) bimetallic complexIdentification of an iridium(III) complex with anti-bacterial and anti-cancer activity.Targeted Inhibition of Snail Activity in Breast Cancer Cells by Using a Co(III) -Ebox Conjugate.Photoinduced electron transfer from PbS quantum dots to cobalt(III) Schiff base complexes: light activation of a protein inhibitor.Spectroscopic elucidation of the inhibitory mechanism of Cys2His2 zinc finger transcription factors by cobalt(III) Schiff base complexes.Recent updates in utilizing prodrugs in drug delivery (2013-2015).The Potent Inhibitory Effect of a Naproxen-Appended Cobalt(III)-Cyclam Complex on Cancer Stem Cells.On the binding modes of metal NHC complexes with DNA secondary structures: implications for therapy and imaging.New perspectives of cobalt tris(bipyridine) system: anti-cancer effect and its collateral sensitivity towards multidrug-resistant (MDR) cancers.Tumor-targeting of EGFR inhibitors by hypoxia-mediated activation.Clinical isolates of Candida albicans, Candida tropicalis, and Candida krusei have different susceptibilities to Co(II) and Cu(II) complexes of 1,10-phenanthroline.Inhibitory effects of different substituted transition metal-based krebs-type sandwich structures on human hepatocellular carcinoma cells.Organometallic Nucleosides: Synthesis and Biological Evaluation of Substituted Dicobalt Hexacarbonyl 2'-Deoxy-5-oxopropynyluridines.Hypoxia-activated prodrugs and redox-responsive nanocarriers
P2860
Q34199803-D943A447-1A43-408A-8EF9-ECA01C7B4429Q35805471-74611A20-A7FC-41F7-924C-A7ED74D4548BQ36102019-F164E46C-1099-437F-8553-BE1D7F78FE27Q36263617-777B657D-C61B-480B-A80A-43D456DE7A21Q37277525-E7379810-1EAC-49C1-9335-BF29D27BDC16Q37542644-62957A12-AC66-41C5-8BD7-21DD8EDC9B02Q38702949-E3022002-D067-435C-98FB-2D2B9B3391D3Q38759894-1A9B065E-9752-418C-9F46-7FD046417AD6Q39399932-D63F1A09-5703-4E47-BA43-5CBE4C3E04C9Q41549887-ACDFA48A-3CE9-42F1-B5CD-FF5D8B2F1072Q42173414-40F03002-B582-4565-B7D4-39D694643F12Q46775225-0FD9B983-360E-4755-8959-D5C8B41B9FF7Q48185356-EFFF63AC-E64C-4155-B292-7736C4487B8CQ55309535-9A0F6E0F-CBE2-4B6A-9E5C-B722F8348740Q58694676-ABD83322-1699-45C4-98F3-B76074693C89
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Cobalt derivatives as promising therapeutic agents
@ast
Cobalt derivatives as promising therapeutic agents
@en
type
label
Cobalt derivatives as promising therapeutic agents
@ast
Cobalt derivatives as promising therapeutic agents
@en
prefLabel
Cobalt derivatives as promising therapeutic agents
@ast
Cobalt derivatives as promising therapeutic agents
@en
P2093
P2860
P1476
Cobalt derivatives as promising therapeutic agents
@en
P2093
Amanda L Eckermann
Marie C Heffern
Natsuho Yamamoto
Robert J Holbrook
Thomas J Meade
P2860
P304
P356
10.1016/J.CBPA.2012.11.019
P577
2012-12-24T00:00:00Z